ZYME ZYMEWORKS INC More: the full row for ZYMEWORKS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 15,028,079 shares; 2025Q1: 17,259,548 shares; 2025Q2: 22,970,388 shares; 2025Q3: 22,970,388 shares; 2025Q4: 22,970,388 shares; 2026Q1: 22,970,388 shares; 2026Q2: 22,970,388 shares; 2026Q3: 22,970,388 shares 22,970,388 $608M 29.91% 0 Timeline ANAB ANAPTYSBIO INC More: the full row for ANAPTYSBIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,873,448 shares; 2025Q1: 7,880,094 shares; 2025Q2: 7,880,094 shares; 2025Q3: 7,880,094 shares; 2025Q4: 7,880,094 shares; 2026Q1: 7,880,094 shares; 2026Q2: 7,880,094 shares; 2026Q3: 7,880,094 shares 7,880,094 $396M 19.47% 0 2026-11-18, Form 4 : bought 138,093 shares on 2026-11-18 Timeline CGON CG ONCOLOGY INC More: the full row for CG ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 772,000 shares; 2026Q1: 1,102,000 shares; 2026Q2: 1,494,300 shares; 2026Q3: 1,871,892 shares 1,871,892 $133M 6.52% +377,592 Timeline ETON ETON PHARMACEUTICALS INC More: the full row for ETON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,829,603 shares; 2025Q1: 1,939,288 shares; 2025Q2: 2,030,544 shares; 2025Q3: 2,030,544 shares; 2025Q4: 2,030,544 shares; 2026Q1: 2,171,938 shares; 2026Q2: 2,171,938 shares; 2026Q3: 2,470,920 shares 2,470,920 $127M 6.25% +298,982 Timeline TRAX FIRST TRACKS BIOTHERAPEUTICS More: the full row for FIRST TRACKS BIOTHERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,174,519 shares; 2026Q3: 3,174,519 shares 3,174,519 $113M 5.53% 0 Timeline AKTS AKTIS ONCOLOGY INC More: the full row for AKTIS ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 4,824,469 shares; 2026Q2: 4,824,469 shares; 2026Q3: 4,824,469 shares 4,824,469 $93.9M 4.62% 0 Timeline CRSP CRISPR THERAPEUTICS AG More: the full row for CRISPR THERAPEUTICS AG Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,389,276 shares; 2025Q1: 1,389,276 shares; 2025Q2: 1,389,276 shares; 2025Q3: 1,389,276 shares; 2025Q4: 1,389,276 shares; 2026Q1: 1,389,276 shares; 2026Q2: 1,389,276 shares; 2026Q3: 1,389,276 shares 1,389,276 $76.9M 3.78% 0 Timeline ANRO ALTO NEUROSCIENCE INC More: the full row for ALTO NEUROSCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,232,000 shares 2,232,000 $57M 2.8% new Timeline LKFT LAKEFRONT BIOTHERAPEUTICS NV More: the full row for LAKEFRONT BIOTHERAPEUTICS NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 155,006 shares; 2025Q1: 155,006 shares; 2025Q2: 1,036,945 shares; 2025Q3: 1,667,119 shares; 2025Q4: 1,667,119 shares; 2026Q1: 1,667,119 shares; 2026Q2: 1,667,119 shares; 2026Q3: 1,667,119 shares 1,667,119 $49.4M 2.43% 0 Timeline ERAS ERASCA INC More: the full row for ERASCA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 900,000 shares; 2026Q2: 330,000 shares; 2026Q3: 2,950,000 shares 2,950,000 $43.2M 2.13% +2,620,000 Timeline ORIC ORIC PHARMACEUTICALS INC More: the full row for ORIC PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,418,068 shares; 2025Q1: 3,418,068 shares; 2025Q2: 1,618,068 shares; 2025Q3: 6,728,116 shares; 2025Q4: 6,728,116 shares; 2026Q1: 6,728,116 shares; 2026Q2: 6,728,116 shares; 2026Q3: 3,028,116 shares 3,028,116 $40.8M 2.01% -3,700,000 Timeline NGNE NEUROGENE INC More: the full row for NEUROGENE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,271,342 shares; 2025Q1: 1,271,342 shares; 2025Q2: 1,271,342 shares; 2025Q3: 1,271,342 shares; 2025Q4: 1,271,342 shares; 2026Q1: 1,271,342 shares; 2026Q2: 1,271,342 shares; 2026Q3: 1,271,342 shares 1,271,342 $35.4M 1.74% 0 Timeline ATTO ATTOVIA THERAPEUTICS INC More: the full row for ATTOVIA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,024,010 shares 2,024,010 $34.7M 1.71% new Timeline FULC FULCRUM THERAPEUTICS INC More: the full row for FULCRUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,549,866 shares; 2026Q3: 6,803,785 shares 6,803,785 $25.2M 1.24% +253,919 Timeline ADRX ADARX PHARMACEUTICALS INC More: the full row for ADARX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,150,000 shares 1,150,000 $22.9M 1.13% new Timeline STOK STOKE THERAPEUTICS INC More: the full row for STOKE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 100,000 shares; 2026Q2: 735,000 shares; 2026Q3: 835,000 shares 835,000 $21.7M 1.07% +100,000 Timeline ZBIO ZENAS BIOPHARMA INC More: the full row for ZENAS BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 789,500 shares; 2026Q1: 789,500 shares; 2026Q2: 789,500 shares; 2026Q3: 789,500 shares 789,500 $21.3M 1.05% 0 Timeline ETRA ELECTRA THERAPEUTICS INC More: the full row for ELECTRA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,700,000 shares 1,700,000 $19.1M 0.94% new Timeline ATRA ATARA BIOTHERAPEUTICS INC More: the full row for ATARA BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 532,134 shares; 2025Q1: 573,183 shares; 2025Q2: 573,183 shares; 2025Q3: 573,183 shares; 2025Q4: 573,183 shares; 2026Q1: 99,593 shares; 2026Q2: 1,552,000 shares; 2026Q3: 1,552,000 shares 1,552,000 $13.2M 0.65% 0 Timeline CAPR CAPRICOR THERAPEUTICS INC More: the full row for CAPRICOR THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,376,580 shares 1,376,580 $13M 0.64% new Timeline XNCR XENCOR INC More: the full row for XENCOR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,144,767 shares; 2025Q1: 6,144,767 shares; 2025Q2: 6,144,767 shares; 2025Q3: 6,144,767 shares; 2025Q4: 3,251,112 shares; 2026Q1: 2,183,000 shares; 2026Q2: not reported; 2026Q3: 500,000 shares 500,000 $12.5M 0.61% new Timeline ODTX ODYSSEY THERAPEUTICS INC More: the full row for ODYSSEY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 555,555 shares; 2026Q3: 555,555 shares 555,555 $12.3M 0.61% 0 Timeline AURA AURA BIOSCIENCES INC More: the full row for AURA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,666,667 shares; 2026Q3: 1,666,667 shares 1,666,667 $10.5M 0.51% 0 Timeline NRIX NURIX THERAPEUTICS INC More: the full row for NURIX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 270,000 shares; 2026Q3: 375,000 shares 375,000 $8.89M 0.44% +105,000 Timeline BRVE BRAVEHEART BIO INC More: the full row for BRAVEHEART BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 416,700 shares 416,700 $8.42M 0.41% new Timeline PHVS PHARVARIS N V More: the full row for PHARVARIS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 235,000 shares; 2026Q3: 235,000 shares 235,000 $7.45M 0.37% 0 Timeline EIKN EIKON THERAPEUTICS INC More: the full row for EIKON THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 732,606 shares; 2026Q2: 732,606 shares; 2026Q3: 855,634 shares 855,634 $6.88M 0.34% +123,028 Timeline ELOX ELOXX PHARMACEUTICALS INC More: the full row for ELOXX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 400,000 shares; 2026Q3: 400,000 shares 400,000 $6.12M 0.3% 0 Timeline AARD AARDVARK THERAPEUTICS INC More: the full row for AARDVARK THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 396,194 shares; 2026Q3: 720,028 shares 720,028 $3.79M 0.19% +323,834 Timeline BBOT BRIDGEBIO ONCOLOGY THERAPEUT More: the full row for BRIDGEBIO ONCOLOGY THERAPEUT Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,823,126 shares; 2025Q4: 2,823,126 shares; 2026Q1: 2,823,126 shares; 2026Q2: 2,823,126 shares; 2026Q3: 889,607 shares 889,607 $3.65M 0.18% -1,933,519 Timeline TCGX TCGX ACQUISITION CORP More: the full row for TCGX ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 250,000 shares 250,000 $3.13M 0.15% new Timeline ZURA ZURA BIO LTD More: the full row for ZURA BIO LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,179,715 shares; 2026Q2: 1,179,715 shares; 2026Q3: 679,715 shares 679,715 $2.83M 0.14% -500,000 Timeline HLXC HELIX ACQUISITION CORP III More: the full row for HELIX ACQUISITION CORP III Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 200,000 shares; 2026Q2: 200,000 shares; 2026Q3: 200,000 shares 200,000 $2.12M 0.1% 0 Timeline CTNM CONTINEUM THERAPEUTICS INC More: the full row for CONTINEUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 64,303 shares 64,303 $863K 0.04% new Timeline